KZIAKAZIA THERAPEUTICS LTD

Nasdaq kaziatherapeutics.com


$ 0.29 $ -0.01 (-4.21 %)    

Monday, 13-May-2024 15:58:02 EDT
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 0.2776
$ 0.28
$ 0.00 x 0
$ 0.00 x 0
$ 0.28 - $ 0.29
$ 0.19 - $ 1.34
201,753
na
6.33M
$ 0.78
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2006 11-06-2006 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 kazia-therapeutics-ltd-entered-into-purchase-agreement-with-alumni-capital-lp-pursuant-to-purchase-agreement-may-sell-to-alumni-capital-up-to-15m-of-american-depositary-shares-from-time-to-time

- SEC Filing

 why-nextplat-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket

Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023...

 why-byrna-technologies-shares-are-trading-higher-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-ex...

 whats-going-with-australia-based-cancer-firm-kazia-therapeutics-on-wednesday

Kazia Therapeutics' Phase 1 trial of paxalisib with radiation therapy in solid tumors, demonstrates safety, clinical activi...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION